ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $9.2 million versus the consensus estimate of $9.23 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.